Medicine and Dentistry
Aortic Valve Stenosis
100%
Pulmonary Hypertension
80%
Low Density Lipoprotein Cholesterol
54%
ST Segment Elevation Myocardial Infarction
52%
Percutaneous Aortic Valve Replacement
51%
Lung Artery Pressure
42%
Pulmonary Artery
30%
Ischemic Heart Disease
30%
Somatomedin Binding Protein 2
30%
Atrial Fibrillation
30%
Hypertrophic Cardiomyopathy
30%
COVID-19
30%
Hypertrophic Obstructive Cardiomyopathy
30%
Isotopes of Calcium
30%
Sudden Cardiac Death
30%
Rivaroxaban
30%
Primary Prevention
27%
Secondary Prevention
24%
Statin
22%
Calcium Ion
21%
Bovine Serum Albumin
12%
Monotherapy
12%
Retrospective Study
12%
Diastolic Function
12%
Thromboprophylaxis
11%
Ezetimibe
9%
Echocardiography
9%
Cardiovascular System
8%
Prematurity
7%
Aortic Valve Prosthesis
6%
Computed Tomography Angiography
6%
Drug Therapy
5%
Diabetes Mellitus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
90%
Aortic Valve Stenosis
75%
Coronavirinae
34%
Disease
34%
Heart Infarction
34%
Bovine Serum Albumin
30%
ST Segment Elevation Myocardial Infarction
30%
Somatomedin Binding Protein 2
30%
Rivaroxaban
30%
Non Insulin Dependent Diabetes Mellitus
30%
Atrial Fibrillation
30%
Sudden Cardiac Death
30%
Empagliflozin
30%
Low Density Lipoprotein Cholesterol
24%
Acute Heart Infarction
18%
Placebo
18%
Cerebrovascular Accident
17%
Hospital Mortality
12%
Mortality Rate
9%
Ezetimibe
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Prematurity
9%
Biological Marker
6%
Survival Rate
5%
Long Term Survival
5%
Statin (Protein)
5%
All Cause Mortality
5%
Retrospective Study
5%
Monotherapy
5%
Diabetes Mellitus
5%
